Trial intelligence / Profile preview

VIT-45 vs Oral Iron in Postpartum Anemia

NCT00396292Phase 3Completed

Sponsor
American Regent, Inc.
Start
Feb 2005
Primary completion
Nov 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ferric carboxymaltose in postpartum anemia, sponsored by American Regent, Inc.. Started Feb 2005; status: completed.

02

Drugs

ferric carboxymaltose
03

Conditions

postpartum anemia

Beyond the preview

Go deeper on NCT00396292.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00396292.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call